SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HuMAB companies
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who wrote (227)9/28/2001 2:29:52 PM
From: aknahow  Read Replies (1) of 1022
 
"These companies are applying the system to select and produce recombinant products in
development, including therapeutic and diagnostic antibodies, vaccines, toxins, and enzymes, as well as recombinant expression
vectors for research use."

"Select, and produce .... therapeutic and diagnostic antibodies...."

Not sure why monoclonal antibodies would be excluded, but just a few years ago I called them monochromal. <g>
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News